EOFlow Partially Wins Appeal in Trade Secret Lawsuit Against Insulet, Restoring Sales in Key Global Markets and Boosting Shareholder Value


  • The U.S. Federal Circuit Court of Appeals partially stayed the permanent injunction issued by the district court in the trade secret and patent infringement lawsuit filed by Insulet, ruling in favor of EOFlow.
  • This decision allows EOFlow to resume product sales to both existing and new customers in South Korea, the European Union, Qatar, Saudi Arabia, and the United Arab Emirates, marking a critical turning point for revenue recovery.
  • While uncertainties remain due to potential further hearings and Insulet's possible additional legal actions, the ruling is positive for corporate value through the resumption of business operations.
  • [AI Summary]EOFlow's appellate victory lifting the sales ban in key markets provides stock price upside momentum from normalization expectations. However, investors should remain cautious given the prolonged litigation risk and Insulet's potential for further appeals.

KOSDAQ Filing Information


  • Judgment/Decision On Lawsuit, Etc. (Trade Secret Misappropriation Under The Defend Trade Secrets Act ("DTSA") And Patent Infringement Lawsuit)
  • Company: EOFlow (294090)
  • Submission: EOFlow Co., Ltd.
  • Under KRX KOSDAQ Market Division

  • Shares: 41,809,105
  • Price: 1,490 KRW
  • Market Cap: 62.3 B KRW